No profile data available.
Azitra, Inc. (AZTR) is a healthcare company in the skin treatment pharmaceuticals industry, based in Branford, United States, with about 13 full-time employees.
It reported revenue of $0 for fiscal year 2025, down 100.0% from fiscal year 2024, and net income of -$10.96 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $0. Its market capitalization was $7.87 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S.
Azitra reported $0 in revenue for fiscal year 2025, down 100.0% from $7,500 in fiscal year 2024. In Q1 2026 revenue was $0.
$7.87 million as of October 9, 2026.
Listed companies of a similar size in the same industry (skin treatment pharmaceuticals) include Fortress Biotech, Inc. (FBIO), Quoin Pharmaceuticals, Ltd. (QNRX), Biofrontera Inc. (BFRI), Dermata Therapeutics, Inc. (DRMA).